Navigation Links
Simcere Pharmaceutical Group Reports Preliminary Unaudited First Quarter 2010 Results
Date:5/18/2010

NANJING, China, May 18 /PRNewswire-Asia/ -- Simcere Pharmaceutical Group ("Simcere" or the "Company") (NYSE: SCR), a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today reported preliminary unaudited financial results for the quarter ended March 31, 2010.

    Highlights
    -- Total revenue was RMB458.7 million (US$67.2 million) for the first
       quarter of 2010, compared to RMB442.5 million for the same period in
       2009, representing year-over-year growth of 3.7%.
    -- Gross margin for the first quarter of 2010 decreased to 79.7% compared
       to 82.5% for the same period in 2009.
    -- Income from operations was RMB30.9 million (US$4.5 million) for the
       first quarter of 2010, a decrease of 49.5% from RMB61.1 million for the
       same period in 2009.
    -- Net income attributable to Simcere was RMB20.5 million (US$3.0 million)
       for the first quarter of 2010, a decrease of 57.5% from RMB48.2 million
       for the same period in 2009.

"While the first quarter remained challenging, we saw solid revenue growth for our edaravone products and were encouraged by the continuing sales recovery of Endu," said Mr. Jinsheng Ren, Chairman and Chief Executive Officer of Simcere Pharmaceutical Group. "We believe that we will see additional benefits arising from the restructuring of our sales force for the remainder of 2010."

"Recently we were pleased to announce that Simcere's diosmectite passed EU-GMP inspection and that Endu successfully completed the Phase IV clinical study which verified the positive resu
'/>"/>

SOURCE Simcere Pharmaceutical Group
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. Simceres Diosmectite API Passes EU-GMP Inspection
2. Simcere Pharmaceutical Group Successfully Completes Endostar Phase IV Clinical Study
3. Simcere Pharmaceutical Group to Announce Fourth Quarter and Fiscal Year 2009 Unaudited Financial Results on Tuesday, March 16, 2010
4. Simcere Receives SFDA Approval to Manufacture and Sell Zanamivir in China
5. Simcere Pharmaceutical Group Provides Update on Jiangsu Yanshen
6. Simcere Pharmaceutical Group Announces Jiangsu Yanshens Voluntary Suspension of Production
7. Simcere Pharmaceutical Group to Acquire Additional Stake in Jiangsu Yanshen Biological Technology Stock Co., Ltd.
8. Simcere Pharmaceutical Group Announces Collaboration with OSI Pharmaceuticals
9. Simcere Pharmaceutical Group Announces Interim Results of Endu Phase IV Clinical Study
10. Epix Pharmaceuticals, Inc. Announces Additional Information Concerning the May 28, 2010 Auction Sale of EP-3600 MRI Imaging Agent
11. Isis Pharmaceuticals to Discuss Its Cancer Franchise in a Conference Call on Wednesday, May 19
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... , Dec. 18, 2014  Decision Resources Group ... the United States will increase to a ... be primarily driven by expansion in the large direct ... devices will be increasingly adopted due to the advantages ... Other key findings from Decision Resources Group,s coverage ...
(Date:12/19/2014)... , Dec. 18, 2014 Since last ... the site now known as the leading online black ... seen explosive growth in its offering of drugs and ... Alliance show the takedowns did succeed in lowering the ... last review of the markets in August. But some ...
(Date:12/17/2014)... SAN DIEGO , Dec. 17, 2014 ... PHIA) and Volcano Corporation (NASDAQ: VOLC ), a ... applications, today announced that they have entered into a definitive ... tender offer to acquire all of the issued and outstanding ... total equity purchase price of USD 1 billion (approx. EUR ...
Breaking Medicine Technology:U.S. Laparoscopic Device Market Will Reach Over $4.3 Billion by 2023 2U.S. Laparoscopic Device Market Will Reach Over $4.3 Billion by 2023 3Post Silk Road - Another Online Drug Den Now Dominates the DarkNet 2Post Silk Road - Another Online Drug Den Now Dominates the DarkNet 3Philips to acquire Volcano to expand global leadership position in image-guided therapy market 2Philips to acquire Volcano to expand global leadership position in image-guided therapy market 3Philips to acquire Volcano to expand global leadership position in image-guided therapy market 4Philips to acquire Volcano to expand global leadership position in image-guided therapy market 5Philips to acquire Volcano to expand global leadership position in image-guided therapy market 6Philips to acquire Volcano to expand global leadership position in image-guided therapy market 7Philips to acquire Volcano to expand global leadership position in image-guided therapy market 8
... July 5, 2011 Allure Medical Spa released an ... and to help them visualize potential outcomes. "Many of ... the newest treatments," explains board certified cosmetic surgeon, Dr. ... digital resource in the palm of their hands that ...
... 5, 2011 Dr. Michael Lowenstein, co-medical director of ... detoxification under deep sedation, is expressing grave concern over ... alarming rise in number of individuals seeking treatment for ... The new national analysis from the U.S. ...
Cached Medicine Technology:Cosmetic Surgery iPhone App Teaches and Amuses 2Waismann Method Medical Director Cautions of Increasing Numbers of Opioid Addicts 2
(Date:12/19/2014)... (PRWEB) December 20, 2014 The Medspa ... new injectable filler from respected cosmetic brand Juvéderm. Voluma ... naturally with age. The Medspa at Hendrick is pleased ... in skin care technology to its clients. , Voluma ... to be FDA-approved to treat the mid-face and cheek ...
(Date:12/19/2014)... Dec. 19, 2014 (HealthDay News) -- New research warns parents that ... lives at risk. Nearly half of teen drivers killed in ... were at least 11 years old and often lacked important safety ... Eighty-two percent of teen drivers killed in crashes were in cars ... to 10 years old, 31 percent were in cars 11 to ...
(Date:12/19/2014)... All children should have their eyesight checked between the ... experts say. The new vision-screening guidelines for preschool-aged ... National Center for Children,s Vision Health. The panel ... for eye problems, particularly vision issues that require ... strabismus (a disorder of eye alignment). Early detection ...
(Date:12/19/2014)... 19, 2014 (HealthDay News) -- Injectable drug users who ... suicide attempt rate of other substance users, a new ... associated with the risk of suicide attempt and completed ... of Montreal, said in a university news release. "However, ... wanted to know who among substance users were actually ...
(Date:12/19/2014)... 2014 (HealthDay News) -- The cost of cancer treatment ... new study finds. Researchers examined data from 1,000 ... with colorectal or lung cancer. Of those patients, almost ... more than 100 had advanced cancer. Nearly half ... their medical bills, which was linked with a poorer ...
Breaking Medicine News(10 mins):Health News:Breakthrough New Injectable Dermal Filler Voluma XC Offered by The MedSpa at Hendrick 2Health News:Older Cars a Bad Choice for Younger Drivers 2Health News:Preschoolers Need Eye Screening, Experts Say 2Health News:Cocaine, Amphetamines May Up Injection Drug Users' Suicide Risk 2Health News:Cancer Treatment Costs Weigh Heavily on Patients, Study Finds 2
... to Follow Dispute Resolution Process is ... the Most Expeditious Path to Final Approval -, ... DDS;,NASDAQ: DDSS) today announced that it has appealed the ... tramadol formulation to,the next supervisory level under the FDA,s ...
... -- Simcere,Pharmaceutical Group (NYSE: SCR ), a ... manufacturer of the patented,anti-cancer biotech product Endu in ... & Co.,s Fourth Investor Tour of China,being held ... 4, 2008 in Beijing,Shenzhen and Shanghai., Simcere,s ...
... New Consumer Label, WICHITA, Kan., April 1, ... that include new best practices,animal husbandry, biosecurity, and ... by VeriPrime, Inc., of Wichita, KS, at the,recommendation ... (Logo: http://www.newscom.com/cgi-bin/prnh/20080401/AQTU070LOGO ), The Advisory Council ...
... Fork, Care and Prevention, WICHITA, Kan., April ... and higher new safety standards, including protections,against E. ... leading farmers and,ranchers behind the food safety seal, ... Citing growing consumer concern over food safety ...
... and OTTAWA, April 1, 2008 Natural,Nutrition, Inc. ... that its operating,subsidiary, InterACTIVE Nutrition, Inc. (INII) achieved ... million (CDN) in EBITDA for the,year ended December ... Nutrition, stated, "We are pleased to,report record results ...
... China,Shenghuo Pharmaceutical Holdings, Inc. (Amex: KUN ) ... the research, development, manufacture,and marketing of pharmaceutical, nutritional ... China ("PRC"), announced its financial,results for full year ... 2007 Highlights -- Net sales totaled ...
Cached Medicine News:Health News:Labopharm Appeals FDA's Decision on Once-Daily Tramadol to Next Supervisory Level After Additional Analysis Supports Efficacy 2Health News:Labopharm Appeals FDA's Decision on Once-Daily Tramadol to Next Supervisory Level After Additional Analysis Supports Efficacy 3Health News:Simcere Pharmaceutical Group Announces Participation in Brean Murray Carret & Co.'s Fourth Investor Tour of China 2Health News:VeriPrime Approves New Best Practices for Beef Production 2Health News:VeriPrime Approves New Best Practices for Beef Production 3Health News:'VeriPrime Certified Safeguards' Food Safety Label Unveiled 2Health News:'VeriPrime Certified Safeguards' Food Safety Label Unveiled 3Health News:Natural Nutrition Subsidiary Reports Record Year-End Revenue and EBITDA 2Health News:China Shenghuo Reports Full Year 2007 Financial Results 2Health News:China Shenghuo Reports Full Year 2007 Financial Results 3Health News:China Shenghuo Reports Full Year 2007 Financial Results 4Health News:China Shenghuo Reports Full Year 2007 Financial Results 5Health News:China Shenghuo Reports Full Year 2007 Financial Results 6Health News:China Shenghuo Reports Full Year 2007 Financial Results 7Health News:China Shenghuo Reports Full Year 2007 Financial Results 8Health News:China Shenghuo Reports Full Year 2007 Financial Results 9Health News:China Shenghuo Reports Full Year 2007 Financial Results 10Health News:China Shenghuo Reports Full Year 2007 Financial Results 11Health News:China Shenghuo Reports Full Year 2007 Financial Results 12Health News:China Shenghuo Reports Full Year 2007 Financial Results 13
Mini-Finesse 5mm Dilating Trocar, hook electrode, two lengths, mini or basic kit....
Thoracoscopy Cannula, reusable, hook electrode, two lengths, mini or basic kit....
... Sleeve consists of a rounded ... to prevent puncture or laceration ... cavity has been entered. The ... the sleeve which enhance security ...
... three separate components: an exchange rod, a dilating ... trocar sleeve. The exchange rod is a rigid ... The dilating obturator is tapered and threaded at ... created by the 10/11mm or the 12mm ENDOPATH ...
Medicine Products: